These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2043481)

  • 1. Terminal transferase expression in acute myeloid leukaemia: biology and prognosis.
    Gucalp R; Paietta E; Weinberg V; Papenhausen P; Dutcher JP; Wiernik PH
    Br J Haematol; 1991 May; 78(1):48-54. PubMed ID: 2043481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia.
    Del Poeta G; Venditti A; Stasi R; Aronica G; Cox MC; Buccisano F; Tamburini A; Bruno A; Maurillo L; Battaglia A; Suppo G; Epiceno AM; Del Moro B; Masi M; Amadori S; Papa G
    Leuk Res; 1999 May; 23(5):451-65. PubMed ID: 10374859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlations.
    Paietta E; Van Ness B; Bennett J; Racevskis J; Gucalp R; Cassileth P; Wiernik PH
    Br J Haematol; 1992 Oct; 82(2):324-31. PubMed ID: 1419814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of terminal transferase (TdT) in acute lymphocytic leukaemia expressing myeloid antigens and TdT positive acute myeloid leukaemia as compared to myeloid antigen negative acute lymphocytic leukaemia.
    Paietta E; Racevskis J; Bennett JM; Wiernik PH
    Br J Haematol; 1993 Jul; 84(3):416-22. PubMed ID: 8217792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.
    Lee EJ; Yang J; Leavitt RD; Testa JR; Civin CI; Forrest A; Schiffer CA
    Leukemia; 1992 Nov; 6(11):1203-9. PubMed ID: 1279324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia.
    Venditti A; Del Poeta G; Buccisano F; Tamburini A; Cox-Froncillo MC; Aronica G; Bruno A; Del Moro B; Epiceno AM; Battaglia A; Forte L; Postorino M; Cordero V; Santinelli S; Amadori S
    Leukemia; 1998 Jul; 12(7):1056-63. PubMed ID: 9665190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal transferase positive acute myeloid leukemia: immunophenotypic characterization and response to induction therapy.
    Lo Coco F; Lopez M; Pasqualetti D; Montefusco E; Cafolla A; Monarca B; Sgadari C; De Rossi G
    Hematol Oncol; 1989; 7(2):167-74. PubMed ID: 2646199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
    Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
    Urbano-Ispizua A; Matutes E; Villamor N; Sierra J; Pujades A; Reverter JC; Feliu E; Cervantes F; Vives-Corrons JL; Montserrat E
    Br J Haematol; 1992 Jun; 81(2):178-83. PubMed ID: 1322689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD7 expression in acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Cox C; Aronica G; Masi M; Bruno A; Simone MD; Buccisano F; Papa G
    Leuk Lymphoma; 1995 Mar; 17(1-2):111-9. PubMed ID: 7539657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
    Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W
    J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TdT+/nonlymphoid antigen+ acute leukemias: immunologic and karyotypic monitoring during therapy and at relapse suggests the transformation of a bipotential stem cell.
    Paietta E; Gucalp R; Papenhausen P; Dutcher JP; Wiernik PH
    Leukemia; 1989 Jul; 3(7):485-91. PubMed ID: 2733453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML.
    Marosi C; Köller U; Koller-Weber E; Schwarzinger I; Schneider B; Jäger U; Vahls P; Nowotny H; Pirc-Danoewinata H; Steger G
    Cancer Genet Cytogenet; 1992 Jul; 61(1):14-25. PubMed ID: 1638477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light scatter characteristics of blast cells in acute myeloid leukaemia: association with morphology and immunophenotype.
    Vidriales MB; Orfao A; López-Berges MC; González M; López-Macedo A; García MA; Galende J; San Miguel JF
    J Clin Pathol; 1995 May; 48(5):456-62. PubMed ID: 7629293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies in myeloid diseases: prognostic use in acute myeloid leukaemia.
    Kristensen JS; Hokland P
    Leuk Res; 1991; 15(8):693-700. PubMed ID: 1895750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
    Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of immunophenotypes to prognostic subgroups of age, WBC, platelet count, and cytogenetics in de novo acute myeloid leukemia.
    Li X; Li J; Du W; Zhang J; Liu W; Chen X; Li H; Huang S; Li X
    APMIS; 2011 Jan; 119(1):76-84. PubMed ID: 21143529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal deoxynucleotidyl transferase expression in acute myelogenous leukemia and myelodysplasia as determined by flow cytometry.
    Huh YO; Smith TL; Collins P; Bueso-Ramos C; Albitar M; Kantarjian HM; Pierce SA; Freireich EJ
    Leuk Lymphoma; 2000 Apr; 37(3-4):319-31. PubMed ID: 10752983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.